Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARTV
EMBC
Add up to 3 more stocks
ARTV
Artiva Biotherapeutics, Inc.
-0.98%
$7.06-0.07Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$345.16M
52W Range
$2.71 - $14.53
EMBC
Embecta Corp.
+1.45%
$5.96+0.08Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$353.89M
52W Range
$2.77 - $14.91
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 4.03 |
| Forward P/E | N/A | 3.38 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.99 | N/A |
| P/S Ratio | N/A | 0.35 |
| P/FCF Ratio | N/A | 2.15 |
| EV/EBITDA | N/A | 5.38 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 59.9% |
| Operating Margin | 0.0% | 24.9% |
| Net Margin | 0.0% | 8.6% |
| ROE | -26.1% | N/A |
| ROA | -24.6% | 6.9% |
| ROIC | -27.2% | 18.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 24.16 | 1.68 |
| Quick Ratio | 24.16 | 1.68 |
| Debt/Equity | 0.03 | N/A |
| Interest Coverage | N/A | 3.07 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 5.4% |
| Payout Ratio | N/A | 21.6% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.